Literature DB >> 2082944

A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota.

D R Wynn1, M Rodriguez, W M O'Fallon, L T Kurland.   

Abstract

A review of multiple sclerosis (MS) case reports, using the unified record system at the Mayo Clinic for the Olmsted County population, revealed age- and sex-adjusted prevalence rates per 100,000 persons of 160 for Olmsted County and 173 for Rochester, Minnesota, on January 1, 1985. The annual age- and sex-adjusted incidence rate per 100,000 person-years from 1975 to 1984 for Olmsted County was 6.2 and for Rochester, 6.3. This incidence rate is significantly higher than what had been reported previously in Rochester (3.6/100,000) or in other communities. The estimated 25-year survival of the MS population was 76.2% +/- 4.5% compared with 87.7% for the general US white population of a similar age and sex. Survival for men was less than for women. There was no increase in survival for patients diagnosed with MS in more recent decades. No significant increase was found in cancer or autoimmune disease rates in the MS patients.

Entities:  

Mesh:

Year:  1990        PMID: 2082944     DOI: 10.1212/wnl.40.5.780

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

1.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 2.  Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Authors:  Elisabetta Vegeto; Valeria Benedusi; Adriana Maggi
Journal:  Front Neuroendocrinol       Date:  2008-04-29       Impact factor: 8.606

Review 3.  Multiple sclerosis in the elderly patient.

Authors:  Amer Awad; Olaf Stüve
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

Review 4.  Multiple sclerosis: a unique immunopathological syndrome of the central nervous system.

Authors:  S F Hunter; M Rodriguez
Journal:  Springer Semin Immunopathol       Date:  1995

5.  A health-related quality of life measure for multiple sclerosis.

Authors:  B G Vickrey; R D Hays; R Harooni; L W Myers; G W Ellison
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

Review 6.  Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.

Authors:  Ruth Dobson; Gavin Giovannoni
Journal:  J Neurol       Date:  2013-01-12       Impact factor: 4.849

7.  Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens.

Authors:  Ioana R Moldovan; Anne C Cotleur; Natacha Zamor; Robert S Butler; Clara M Pelfrey
Journal:  J Neuroimmunol       Date:  2007-11-26       Impact factor: 3.478

8.  Multiple sclerosis in the province of Ferrara : evidence for an increasing trend.

Authors:  E Granieri; N-T Economou; R De Gennaro; M R Tola; L Caniatti; V Govoni; E Fainardi; I Casetta
Journal:  J Neurol       Date:  2007-11-16       Impact factor: 4.849

Review 9.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

10.  Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway.

Authors:  R Midgard; G Albrektsen; T Riise; G Kvåle; H Nyland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.